That's not how it works, firstly a patient can be diagnosis as having multiple respiratory diseases from the one cough sample.
So from the 400 example, they could count for 500 patients which accounted for 200 misdiagnosis of URTI, 200 for LRTI, 50 for Asthma/Reactive Airway, 10 for Bronchiolitis and 40 for Pneumonia or any other variation, hence, it was a total stuff up in the clinical trials datasets as no-one truly knows, RAP can only analysis what want wrong and redo the tests.
- Forums
- ASX - By Stock
- RAP
- Sorry Rappers
Sorry Rappers, page-235
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online